Fulgent Genetics, Inc. (NAS: FLGT) Stock Analysis & Fundamentals | ScreenerHero

Create free account

FLGTFulgent Genetics, Inc.

NAS · US · Healthcare · Diagnostics & Research · fulgentgenetics.com

20.52USD-0.05%Mkt Cap: 582.78M $P/E: —1d ago

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap582.78M $

Enterprise Value310.99M $

Revenue (TTM)320.35M $

Gross Profit130.88M $

Net Income (TTM)-60.51M $

Revenue/Share10.40 USD

Last Price20.52 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS3596641098

Valuation

P/E (Trailing)—

P/E (Forward)-13.43

PEG—

EV/EBITDA-4.03

EV/Revenue0.97

P/S1.82

P/B0.56

EPS (TTM)-2.40

EPS (Forward)-1.53

52W Range

13.4640% of range31.04

52W High31.04 USD

52W Low13.46 USD

Profitability

Gross Margin40.56%

Oper. Margin-45.01%

EBITDA Margin-24.10%

Profit Margin-18.75%

ROE-5.44%

ROA-4.99%

Growth

Revenue Growth-3.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-101.64M $

CapEx (TTM)22.57M $

FCF Margin-33.07%

FCF Yield-18.18%

Net Debt-266.13M $

Net Debt/EBITDA3.45

Balance Sheet

Debt/Equity0.01

Current Ratio5.32

Quick Ratio3.91

Book Value/Sh36.39 USD

Cash/Share9.729 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)18.50 USD

Upside (mean)-9.8%

Target Range15.00 USD – 22.00 USD

$15.00-9.8% to mean$22.00

# Analysts2

Ownership

Shares Out.28.40M

Float17.56M

Insiders36.66%

Institutions63.45%

Short Interest

Short Ratio5.7d

Short % Float15.14%

Short % Out.9.61%

Shares Short2.73M

Short (prev mo.)2.72M

Technical

SMA 5017.12 (+19.9%)

SMA 20021.63 (-5.1%)

Beta0.92

S&P 52W Chg20.05%

Avg Vol (30d)349.25K

Avg Vol (10d)330.76K

Technical Indicators

RSI (14)70.4

MACD0.7146

MACD Signal0.5550

MACD Hist.+0.1596

BB Upper20.48 USD

BB Middle18.81 USD

BB Lower17.14 USD

BB Width17.77%

ATR (14)0.6934 USD

Vol Ratio (20d)0.71x